Alexandria Real Estate Equities第三季度净亏损6.385亿美元：待售资产减值6.379亿美元，调整后FFO每股1.54美元
总部位于美国加利福尼亚州洛杉矶县 Pasadena 的生命科学地产信托 Alexandria Real Estate Equities（纽约证券交易所代码：ARE）10月26日公布截至2026年9月30日的第三季度业绩：归属普通股股东净亏损6.385亿美元、每股亏损3.74美元，其中包含与待售资产相关的6.379亿美元房地产减值费用；调整后每股运营资金（FFO）为1.54美元，低于去年同期的2.22美元；季度总营收6.712亿美元。
运营方面，公司经营物业入住率为87.1%，计入已签约待入住租约后为90.8%。第三季度租赁总量超过123.6万平方英尺，为2024年第四季度以来最高，其中此前空置空间的租赁达450,961平方英尺，为公司历史第二高；过去十二个月的租赁活动74%来自现有租户。同物业净营业收入同比下降6.7%，公司称主因是此前披露的关键租约到期带来的约28.3万平方英尺停租期。
资本回收方面，公司10月完成出售 Campus Point by Alexandria 巨型园区约29%的非控股权益，作价4.75亿美元；截至10月26日，今年已完成的非核心与土地处置及部分权益出售合计7.17亿美元，全年指引中值为19亿美元。公司流动性达45.6亿美元，50亿美元无担保高级信贷额度已展期至2032年，全部债务中仅6%在2028年年底前到期。
开发交付方面，第三季度共有529,061平方英尺的开发与重开发项目投入使用，交付时入住率84%，新增年净营业收入约4,000万美元，其中包括 Novo Nordisk 位于 Waltham 的研发中心（198,992平方英尺）。公司同时宣布，已签约出售 Fenway 生命科学园区 421 Park Drive 项目（339,668平方英尺），预计可减少未来建设支出约1.36亿美元，交易预计第四季度完成。
Alexandria Real Estate Equities Posts $638.5 Million Third-Quarter Net Loss on $637.9 Million Impairment; Adjusted FFO $1.54 Per Share
Alexandria Real Estate Equities, Inc. (NYSE: ARE), the Pasadena, California-based life science real estate investment trust headquartered in Los Angeles County, reported third-quarter 2026 results on October 26. The net loss attributable to common stockholders was $638.5 million, or $3.74 per share, including $637.9 million of real estate impairment charges related to assets held for sale. Funds from operations per share, as adjusted, were $1.54, down from $2.22 a year earlier, and total revenues were $671.2 million for the quarter ended September 30, 2026.
Operating property occupancy stood at 87.1%, or 90.8% including executed leases with future occupancy. Third-quarter leasing volume surpassed 1.2 million rentable square feet, the highest quarterly total since the fourth quarter of 2024, including 450,961 square feet of previously vacant space, the second-highest quarterly amount in company history. Same property net operating income fell 6.7% year over year, which the company attributed primarily to downtime from previously disclosed key lease expirations.
On capital recycling, Alexandria closed the sale in October of an approximately 29% noncontrolling interest in the Campus Point by Alexandria Megacampus for $475.0 million. Completed dispositions and sales of partial interests totaled $717 million as of October 26, against full-year guidance with a midpoint of $1.9 billion. Liquidity stood at $4.56 billion, its $5.0 billion unsecured senior line of credit was extended to 2032, and only 6% of total debt matures through 2028.
The company placed 529,061 square feet of development and redevelopment projects into service during the quarter, 84% occupied at delivery, generating about $40 million of incremental annual net operating income, including 198,992 square feet delivered to Novo Nordisk for its R&D center in Waltham. It also signed an agreement to sell its 421 Park Drive project at the Fenway Megacampus, expected to cut future construction spending by about $136 million and to close in the fourth quarter.
来源：GSM·美国（原文链接）
图片来源：图：生命科学研究建筑外观（资料图，非该公司物业）。图片：美国国家标准与技术研究院 NIST，公共领域（Wikimedia Commons）。Photo: A life science research building (file photo, not a company property). Credit: National Institute of Standards and Technology (NIST), public domain, via Wikimedia Commons.
